These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia? Harris AG; Saikal SL; Scurry J; Relic J; Nixon RL; Chee P Australas J Dermatol; 2019 Feb; 60(1):53-56. PubMed ID: 30155971 [TBL] [Abstract][Full Text] [Related]
25. Exacerbation of allergic contact dermatitis from amcinonide triggered by patch testing. Sasseville D Contact Dermatitis; 2001 Oct; 45(4):232-3. PubMed ID: 11683835 [No Abstract] [Full Text] [Related]
26. [Severe contact dermatitis caused by Parfenac cream]. Collet E; Lacroix M; Boulitrop Morvan C; Dalac S; Sallin J; Lambert D Ann Dermatol Venereol; 1993; 120(12):892-3. PubMed ID: 8074349 [TBL] [Abstract][Full Text] [Related]
30. Allergic contact dermatitis from 6alpha-methylprednisolone aceponate and budesonide. Corazza M; Virgili A Contact Dermatitis; 1998 Jun; 38(6):356-7. PubMed ID: 9687052 [No Abstract] [Full Text] [Related]
31. Contact dermatitis from anti-inflammatory gel containing hydroxyethyl salicylate. Horak J; Hemmer W; Focke M; Götz M; Jarisch R Contact Dermatitis; 2002 Aug; 47(2):120-1. PubMed ID: 12455553 [No Abstract] [Full Text] [Related]
32. Contact allergy to topical corticosteroids: a screening study with a corticosteroid mix. Portuguese Contact Dermatitis Research Group (GPEDC). Pecegueiro M Contact Dermatitis; 1995 Sep; 33(3):196-7. PubMed ID: 8565463 [No Abstract] [Full Text] [Related]